# A Study of the Safety and Effectiveness of Two New Malaria Vaccines

> **NCT01003314** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 16 (estimated)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** AdCh63-MSP1 (lower dose) vaccine and MVA-MSP1 vaccine
- **BIOLOGICAL:** AdCh63-MSP1 vaccine (higher dose) and MVA-MSP1 vaccine followed by challenge

## Key facts

- **NCT ID:** NCT01003314
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2011-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01003314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01003314, "A Study of the Safety and Effectiveness of Two New Malaria Vaccines". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01003314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*